Bariş, V. Ö. Et Al. 2021. Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.. Kardiologia polska , vol.79, no.1 , 53-57.

Bariş, V. Ö., Dinçsoy, B., Gedikli, E., & ERDEM, A., (2021). Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.. Kardiologia polska , vol.79, no.1, 53-57.

Bariş, Veysel Et Al. "Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.," Kardiologia polska , vol.79, no.1, 53-57, 2021

Bariş, Veysel Ö. Et Al. "Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.." Kardiologia polska , vol.79, no.1, pp.53-57, 2021

Bariş, V. Ö. Et Al. (2021) . "Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.." Kardiologia polska , vol.79, no.1, pp.53-57.

@article{article, author={Veysel Özgür Bariş Et Al. }, title={Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.}, journal={Kardiologia polska}, year=2021, pages={53-57} }